Clinical trials

  • Ambroxol hydrochloride for Dementia with Lewy Bodies
  • PERTUZUMAB for Advanced (locally advanced or metastatic) cancer
  • FEZOLINETANT for Vasomotor symptoms (hot flashes) | Hormone receptor-positive breast cancer
  • IPTACOPAN for ANCA-associated vasculitis|Granulomatosis with polyangiitis (GPA)|Microscopic polyangiitis (MPA)
  • RITUXIMAB for Membranous nephropathy
  • DEXPANTHENOL for Radiation-induced oral mucositis | Head and neck cancer
  • GOSERELIN for Prostate cancer
  • INOTUZUMAB OZOGAMICIN for B-cell acute lymphoblastic leukemia | Minimal residual disease-positive B-cell acute lymphoblastic leukemia
  • LETROZOLE for Estrogen receptor-positive, HER2-negative metastatic breast cancer
  • AZACITIDINE for Myelodysplastic syndrome (high-risk)
  • ELACESTRANT for Hormone receptor-positive HER2-negative breast cancer (node-positive, non-metastatic, stage II-III)
  • durvalumab for Non-small cell lung cancer (Stage III)